REFERENCES
- Akiba J, Arzabe C W, Trempe C L. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology. 1990; 97(7)889–891, [PUBMED], [INFOTRIEVE], [CSA]
- Capeans C, Lorenzo J, Santos L, Suarez A, Copena M J, Blanco M J, Sanchez-Salorio M. Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1998; 236(7)481–485, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Avunduk A M, Cetinkaya K, Kapicioglu Z, Kaya C. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand. 1997; 75(4)441–442, [PUBMED], [INFOTRIEVE], [CSA]
- Hikichi T, Yoshida A, Konno S, Trempe C L. Role of the vitreous in central retinal vein occlusion. Nippon Ganka Gakkai Zasshi. 1996; 100(1)63–68, [PUBMED], [INFOTRIEVE], [CSA]
- Koerner F, Garweg J. [Diseases of the vitreo-macular interface.]. Klin Monatsbl Augenheilkd. 1999; 214(5)305–310, [PUBMED], [INFOTRIEVE], [CSA]
- Gastaud P, Betis F, Rouhette H, Hofman P. [Ultrastructural findings of epimacular membrane and detached posterior hyaloid in vitreomacular traction syndrome.]. J Fr Ophtalmol. 2000; 23(6)587–593, [PUBMED], [INFOTRIEVE], [CSA]
- Gass J D. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995; 119(6)752–759, [PUBMED], [INFOTRIEVE], [CSA]
- Ebato K, Kishi S. Spontaneous closure of macular hole after posterior vitreous detachment. Ophthalmic Surg Lasers. 2000; 31(3)245–247, [PUBMED], [INFOTRIEVE], [CSA]
- Koerner F, Garweg J. Vitrectomy for macular pucker and vitreomacular traction syndrome. Doc Ophthalmol. 1999; 97(3–4)449–458, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ondes F, Yilmaz G, Acar M A, Unlu N, Kocaoglan H, Arsan A K. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol. 2000; 44(1)91–93, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 2000; 15(1)51–61, [PUBMED], [INFOTRIEVE], [CSA]
- Trese M T. Enzymatic vitreous surgery. Semin Ophthalmol. 2000; 15(2)116–121, [PUBMED], [INFOTRIEVE], [CSA]
- Verstraeten T C, Chapman C, Hartzer M, Winkler B S, Trese M T, Williams G A. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993; 111(6)849–854, [PUBMED], [INFOTRIEVE], [CSA]
- Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999; 19(1)55–58, [PUBMED], [INFOTRIEVE], [CSA]
- Gandorfer A, Putz E, Welge-Lussen U, Gruterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001; 85(1)6–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J, Grabner G, Kampik A. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002; 133(1)156–159, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gandorfer A, Ulbig M, Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye. 2002; 16(1)95–97, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Unal M, Peyman G A. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment. Retina. 2000; 20(1)69–75, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Margherio A R, Margherio R R, Hartzer M, Trese M T, Williams G A, Ferrone P J. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998; 105(9)1617–1620, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chow D R, Williams G A, Trese M T, Margherio R R, Ruby A J, Ferrone P J. Successful closure of traumatic macular holes. Retina. 1999; 19(5)405–409, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Trese M T, Williams G A, Hartzer M K. A new approach to stage 3 macular holes. Ophthalmology. 2000; 107(8)1607–1611, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Williams J G, Trese M T, Williams G A, Hartzer M K. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001; 108(10)1902–1905, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002; 240(1)56–62, [PUBMED], [INFOTRIEVE], [CSA]
- Russell S R, Shepard J D, Hageman G S. Distribution of glycoconjugates in the human retinal ILMs. Invest Ophthalmol Vis Sci. 1991; 32: 1986–1995, [PUBMED], [INFOTRIEVE], [CSA]
- Wallen P, Wiman B. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations. Biochim Biophys Acta. 1970; 221(1)20–30, [PUBMED], [INFOTRIEVE], [CSA]
- Wallen P, Wiman B. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen. Biochim Biophys Acta. 1972; 257(1)122–134, [PUBMED], [INFOTRIEVE], [CSA]
- Wallen P, Wiman B. Amino acid sequence around the arginyl-valyl bond in plasminogen which is cleaved during the second step of the activation process. Thromb Res. 1975; 7(1)239–243, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Whitefleet-Smith J, Rosen E, McLinden J, Ploplis V A, Fraser M J, Tomlinson J E, McLean J W, Castellino F J. Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. Arch Biochem Biophys. 1989; 271(2)390–399, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang J, Brdar B, Reich E. Structure and function of microplasminogen: I. Methionine shuffling, chemical proteolysis, and proenzyme activation. Protein Sci. 1995; 4(9)1758–1767, [PUBMED], [INFOTRIEVE], [CSA]
- Wang J, Reich E. Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase. Protein Sci. 1995; 4(9)1768–1779, [PUBMED], [INFOTRIEVE], [CSA]
- Junqing Shen, Houyan Song. Construction and expression of human microplasminogen gene in Escherichia coli. Chinese J Biotechnol. 1997; 13(1)65–69, [CSA]
- Gandorfer A, Rohleder M, Sethi C, Eckle D, Welge-Lussen U, Kampik A, Luthert P, Charteris D. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004; 45(2)641–647, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peng Y i, Wei Bu, Liangyi Kang. Methylotrophic yeast system. Biotechnol Information. 2000; 1: 38–41, [CSA]
- Lin Cereghino Joan, James M. Cregg. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000; 24: 45–66, [CSA], [CROSSREF]
- Nagai N, Demarsin E, Van Hoef B, Wouters S, Cingolani D, Laroche Y, Collen D. Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost. 2003; 1(2)307–313, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mutch N J, Moore N R, Wang E, Booth N A. Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI. J Thromb Haemost. 2003; 1(9)2000–2007, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu Q, Zhao Z. Inhibition of PAI-1: a new anti-thrombotic approach. Curr Drug Targets Cardiovasc Haematol Disord. 2002; 2(1)27–42, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boxrud P D, Fay W P, Bock P E. Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen. J Biol Chem. 2000; 275(19)14579–14589, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boxrud P D, Verhamme I MA, Fay W P, Bock P E. Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation. J Biol Chem. 2001; 276(28)26084–26089, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang S, Reed G L, Hedstrom L. Zymogen activation in the streptokinase–plasminogen complex. Eur J Biochem. 2000; 267: 3994–4001, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Torrens I, Ojalvo A G, Seralena A, Hayes O, de la Fuente J. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic. Immunol Lett. 1999; 70(3)213–218, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ojalvo A G, Torrens I, Seralena A, de la Fuente J. Recombinant streptokinase with reduced immunoreactivity. Thromb Hemost. 817, [CSA]
- Pautov V D, Anufrieva E V, Ananeva T D, Saveleva N V, Taratina T M, Krakovyak M G. Structural dynamic and functional properties of native and modified streptokinase. Mol Biol. 1990; 24: 35–41, [CSA]
- Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Chin Med J (Engl). 1997; 110(1)50–52, [CSA]
- Cherfan G M, Maghraby A, Tabbara K F, Nasr Y, Hassan H. Dissolution of intraocular fibrinous exudate by streptokinase. Ophthalmology. 1991; 98(6)870–874, [PUBMED], [INFOTRIEVE], [CSA]